Bio logo
Making and Taking Fit for the future Digital Outcomes

Technology & Innovation Centre

21-22 September 2022, GLASGOW

PharmaTech Integrates 2022

Technology & Innovation Centre, 21-22 September 2022, GLASGOW

PHARMATECH INTEGRATES 2022 AGENDA

KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS


In addition, there will be the opportunity to attend a tour of the Medicines Manufacturing Innovation Centre on Wednesday 21 September from 13:00 – 16:00. You can be one of the first to see this brand new facility and you’ll also be able to network and hear from the Medicines Manufacturing Innovation Centre and wider CPI teams who will be available to discuss each of the Grand Challenges. Refreshments will be provided.

On the day of the event CMAC, who are based within the Technology and Innovation Centre, will also be offering a tour of their world-class facilities. This will provide you the opportunity to meet with key researchers and to see the innovative technologies they are developing, including the robotics they have integrated into the Digital CMC and data-factory stream.


 

MAKING AND TAKING

Focusing on advances in manufacturing, formulation and drug delivery technologies

FIT FOR THE FUTURE

Focusing on new therapies and the technology developments required for them to realise their full potential

DIGITAL OUTCOMES

Defining and implementing the right digital and data strategies for Pharma’s future

Registration and Networking

08:00 – 09:00

Registration and Networking

Welcome & Opening Remarks

09:00 – 09:10

Welcome & Opening Remarks

DAVE TUDOR | Managing Director | MMIC, Biologics & Quality

Fireside Chat

09:10 – 09:30

Fireside Chat

MARTIN MEESON | Chief Executive Officer | FUJIFILM Diosynth Biotechnologies

Fireside Chat

09:30 – 09:50

Fireside Chat with

MAUREEN WEDDERBURN | Non Executive Chair | Medicines Manufacturing Innovation Centre
STEVEN BAGSHAW CBE | Bio industrial Specialist and Non-Executive Director | CPI

Morning refreshment

09:50 – 10:30

Morning Refreshment & Networking

Session 1

10:30 – 11:20

Pro-Active Ingredients

Building on the advances in process intensification and continuous manufacturing to further enhance the efficiency and quality of active ingredients manufacturing.

Gene Genie

Identifying the next steps to drive forward the potential of oligonucleotides, DNA and RNA based therapeutics

Making Predictions

Using AI, VR, simulations and digital twins to support pharma from drug development, process scale-up, facility design and operator training

Session 2

11:30 – 12:20

Implications of Point of Care and Distributed Manufacture

As medicines become more stratified and manufacturing runs become smaller, how should the manufacturing network change to keep up?

ADC… it’s as easy as 1,2,3…4?

The accelerating growth in Antibody Drug Conjugate (ADC) development and commercialisation provides an exciting outlook for targeted therapies

Rise of robotics

How can robotics and automated systems optimise the development of medicines to lower the costs, reduce the environmental impact and increase the speed to market?

Lunch Break

12:20 – 13:30

Lunch & Networking

Session 3

13:30 – 14:20

Free Form Thinking

Applying the rapidly advancing knowledge and technologies for the control of physical form and formulation to enhance product application, performance and safety

Please join track 1 or 3

Please join Track 1 or 3

Silicon rally

Speeding the adoption of real time data collection and systems integration to enhance the productivity, quality, reproducibility and compliance of pharma production processes.

Session 4

14:30 – 15:20

Special Delivery

How finished dose form technologies are advancing to deliver more efficient products, better supply chains and improved patient outcomes

Hard Cell

Addressing the considerable challenges for improving the production of advanced cell and gene therapies.

Digital, Data and the Pharma Supply Chain

Digital and Data based solutions for more effective and efficient pharm supply chains and logistics, which enhance patient access and reduce healthcare costs

Drinks reception

15:20 – 16:30

Drinks reception & Networking

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Bio logo
Making and Taking Fit for the future Digital Outcomes

Technology & Innovation Centre

21-22 September 2022, GLASGOW

Bio logo
Making and Taking Fit for the future Digital Outcomes

Technology & Innovation Centre

21-22 September 2022, GLASGOW

PharmaTech Integrates 2022

Technology & Innovation Centre, 21-22 September 2022, GLASGOW

PHARMATECH INTEGRATES 2022 AGENDA

KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS


In addition, there will be the opportunity to attend a tour of the Medicines Manufacturing Innovation Centre on Wednesday 21 September from 13:00 – 16:00. You can be one of the first to see this brand new facility and you’ll also be able to network and hear from the Medicines Manufacturing Innovation Centre and wider CPI teams who will be available to discuss each of the Grand Challenges. Refreshments will be provided.

On the day of the event CMAC, who are based within the Technology and Innovation Centre, will also be offering a tour of their world-class facilities. This will provide you the opportunity to meet with key researchers and to see the innovative technologies they are developing, including the robotics they have integrated into the Digital CMC and data-factory stream.


 

Registration and Networking

08:00 – 09:00

Welcome & Opening Remarks

09:00 – 09:10

DAVE TUDOR | Managing Director | MMIC, Biologics & Quality

Fireside Chat

09:10 – 09:30

MARTIN MEESON | Chief Executive Officer | FUJIFILM Diosynth Biotechnologies

 

Fireside Chat

09:30 – 09:50

MAUREEN WEDDERBURN | Non Executive Chair | Medicines Manufacturing Innovation Centre
STEVEN BAGSHAW CBE | Bio industrial Specialist and Non-Executive Director | CPI

Morning Refreshment and Networking

09:50 – 10:30

MAKING AND TAKING

Focusing on advances in manufacturing, formulation and drug delivery technologies

Session 1

10:30 – 11:20

Pro-Active Ingredients

Building on the advances in process intensification and continuous manufacturing to further enhance the efficiency and quality of active ingredients manufacturing.

Session 2

11:30 – 12:20

Implications of Point of Care and Distributed Manufacture

As medicines become more stratified and manufacturing runs become smaller, how should the manufacturing network change to keep up?

What structural challenges do these changes present and how can we use manufacturing innovation and digital tools, along with updated regulatory strategies, to grasp the opportunities?

Lunch and Networking

12:20 – 13:30

Session 3

13:30 – 14:20

Free Form Thinking

Applying the rapidly advancing knowledge and technologies for the control of physical form and formulation to enhance product application, performance and safety

Session 4

14:30 – 15:20

Special Delivery

How finished dose form technologies are advancing to deliver more efficient products, better supply chains and improved patient outcomes

FIT FOR THE FUTURE

Focusing on new therapies and the technological advances in manufacturing required to support them

Session 1

10:30 – 11:20

Gene Genie

Identifying the next steps to drive forward the potential of oligonucleotides, DNA and RNA based therapeutics

Session 2

11:30 – 12:20

ADC… it’s as easy as 1,2,3…4?

The accelerating growth in Antibody Drug Conjugate (ADC) development and commercialisation provides an exciting outlook for targeted therapies – but with four complex, disparate, components to bring together (antibody, toxin-linker, bioconjugation, sterile fill-finish), what does the current partnership model look like, and how must CDMOs evolve to meet future development and manufacturing requirements in this space?

Lunch & Networking

12:20 – 13:30

Session 3

13:30 – 14:20

Please join track 1 or 3

Please join Track 1 or 3

Session 4

14:30 – 15:20

Hard Cell

Addressing the considerable challenges for improving the production of advanced cell and gene therapies.

DIGITAL OUTCOMES

Defining and implementing the right digital and data strategies for Pharma’s future

 

Session 1

10:30 – 11:20

Making Predictions

Using AI, VR, simulations and digital twins to support pharma from drug development, process scale-up, facility design and operator training

Session 2

11:30 – 12:20

Rise of robotics

The 4th industrial revolution has seen the development and uptake of advanced robotics and automated systems to carry out tasks that can be classed as Dangerous, Dirty, Dull, Dear or Difficult, or that can require or generate Data, often in sectors with similar degrees of regulation. As the pharma industry seeks to reduce the time to market for new therapies in a manner that lowers cost and reduces environmental impact, this session will explore the role for increased adoption of these technologies to help achieve these objectives.

Lunch & Networking

12:20 – 13:30

Session 3

13:30 – 14:20

Silicon rally

Speeding the adoption of real time data collection and systems integration to enhance the productivity, quality, reproducibility and compliance of pharma production processes.

Session 4

14:30 – 15:20

Digital, Data and the Pharma Supply Chain

Digital and Data based solutions for more effective and efficient pharm supply chains and logistics, which enhance patient access and reduce healthcare costs

Drinks Reception

15:20 – 16:30

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Bio logo
Making and Taking Fit for the future Digital Outcomes

Technology & Innovation Centre

21-22 September 2022, GLASGOW